The Discounted Cash Flow (DCF) valuation of Biogen Inc (BIIB) is 238.66 USD. With the latest stock price at 217.15 USD, the upside of Biogen Inc based on DCF is 9.9%.
Based on the latest price of 217.15 USD and our DCF valuation, Biogen Inc (BIIB) is a buy. buying Biogen stocks now will result in a potential gain of 9.9%.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.8% | 7.5% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 149.71 - 508.20 | 238.66 |
| Upside | -31.1% - 134.0% | 9.9% |